Baseline endemicity level (microfilarial prevalence) | 1% cumulative reduction in microfilarial production by female adult worms per dose | 7% cumulative reduction in microfilarial production by female adult worms per dose | 30% cumulative reduction in microfilarial production by female adult worms per dose | ||||||
---|---|---|---|---|---|---|---|---|---|
Projected duration, in years, of treatment programme (relative cost, in percent) | Projected duration, in years, of treatment programme (relative cost, in percent) | Projected duration, in years, of treatment programme (relative cost, in percent) | |||||||
aCDTI | bCDTI (ǂ) | aCDTM (ǂ,†) | aCDTI | bCDTI (ǂ) | aCDTM (ǂ,†) | aCDTI | bCDTI (ǂ) | aCDTM (ǂ,†) | |
Mesoendemic (40%) | 21 | 14 (118%) | 12 (65%, 55%) | 17 | 11 (113%) | 11 (71%, 63%) | 12 | 9 (126%) | 10 (86%, 68%) |
Hyperendemic (60%) | 33 | 20 (115%) | 18 (67%, 58%) | 25 | 16 (116%) | 17 (76%, 66%) | 17 | 14 (138%) | 15 (91%, 66%) |
Highly-hyperendemic (80%) | NA | 38 (140%) | 30 (76%, 54%) | NA | 26 (112%) | 26 (70%, 63%) | 38 | 22 (114%) | 23 (74%, 65%) |